Protalix Biotherapeutics Inc (PLX) Technical Analysis
$1.76▲1.15%
Market is closed - opens 8 PM, 23 Dec 2024
Insights
- Protalix Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Protalix Biotherapeutics stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Protalix Biotherapeutics stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Protalix Biotherapeutics stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 63.36 | Sell |
Stochastic | 73.07, 64.09 | Neutral |
Ultimate Oscillator | 67.17 | Neutral |
Stochastic Relative Strength Index | 14.22, 7.13 | Buy |
Moving Average Convergence Divergence | 0.09, 0.11 | Sell |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.77 | Buy |
20 | 1.72 | Buy |
50 | 1.43 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.74 | Buy |
20 | 1.69 | Buy |
50 | 1.5 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.77 | Neutral |
20 | 1.73 | Neutral |
50 | 1.52 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.77 | Sell |
20 | 1.82 | Buy |
50 | 1.74 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.74 | Sell |
20 | 1.79 | Sell |
50 | 1.85 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 1.86 |
Resistance L2 | 1.8 |
Resistance L1 | 1.77 |
Pivot Point | 1.71 |
Support L1 | 1.68 |
Support L2 | 1.62 |
Support L3 | 1.59 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.